Skip to main content
. 2025 Jul 29;26(15):7308. doi: 10.3390/ijms26157308
APH Aphidicolin
BLCA bladder urothelial carcinoma
BRCA breast invasive carcinoma
BRCT BRCA1 C terminus
CLOW claudin-low breast cancer subtype
COAD colon adenocarcinoma
DSB DNA double-strand break
ER oestrogen receptor
GO Gene Ontology
HER2 Human Epidermal Growth Factor Receptor 2
HER2E Human Epidermal Growth Factor Receptor 2-Enriched Breast Cancer Subtype
KM Kaplan–Meier
KIRC kidney renal clear-cell carcinoma
LIHC liver hepatocellular carcinoma
LUAD lung adenocarcinoma
LumA Luminal A breast cancer subtype
LumB Luminal B breast cancer subtype
LUSC squamous cell lung cancer
NSCLC non-small cell lung cancer
PAM50 Prediction Analysis of Microarray 50
PR progesterone receptor
PRAD prostate adenocarcinoma
PSI percent spliced in
TCGA The Cancer Genome Atlas
THCA thyroid carcinoma